Pooled analysis of topotecan (T) in the second-line treatment of patients (pts) with sensitive small cell lung cancer (SCLC)

被引：0
|
作者：
Eckardt, J
Depierre, A
Ardizzoni, A
VonPawel, J
Fields, S
机构：
[1] ST JOHNS MERCY HOSP,ST LOUIS,MO
[2] HOP ST JACQUES,F-25030 BESANCON,FRANCE
[3] ZENT KRANKENHAUS GAUTING,D-82131 GAUTING,GERMANY
[4] SMITHKLINE BEECHAM PHARMACEUT,COLLEGEVILLE,PA 19426
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1041 / 1041
页数：1
相关论文
共 50 条
  • [1] Topotecan effective for second-line treatment of small cell lung cancer
    不详
    IRISH MEDICAL JOURNAL, 1997, 90 (05) : 198 - 198
  • [2] Randomized phase 3 trial of amrubicin versus topotecan as second-line treatment for small cell lung cancer (SCLC)
    von Pawel, J.
    Jotte, R.
    Spigel, D. R.
    Socinski, M. A.
    O'brien, M. E. R.
    Pashold, E. H.
    Mezger, J.
    Steins, M.
    Bosquee, L.
    Bubis, J.
    Nackaerts, K.
    Trigo, J. M.
    Clingan, P.
    Schuette, W.
    Lorigan, P. C.
    Reck, M.
    Domine, M.
    Shepard, F. A.
    Mcnally, R.
    Renschler, M. F.
    ONKOLOGIE, 2011, 34 : 122 - 124
  • [3] The role of topotecan in treating small cell lung cancer: second-line treatment
    von Pawel, J
    LUNG CANCER, 2003, 41 : S3 - S8
  • [4] Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: A pooled analysis of topotecan second-line trials
    Ardizzoni, Andrea
    Tiseo, Marcello
    Boni, Luca
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (13) : 2211 - 2218
  • [5] OUR EXPERIENCE WITH TOPOTECAN AS SECOND-LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2010, 16 (03): : 70 - 73
  • [6] Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC).
    Jotte, R.
    Von Pawel, J.
    Spigel, D. R.
    Socinski, M. A.
    O'Brien, M.
    Paschold, E. H.
    Mezger, J.
    Steins, M.
    Bosquee, L.
    Bubis, J. A.
    Nackaerts, K.
    Perez, J. M. Trigo
    Clingan, P. R.
    Schuette, W.
    Lorigan, P.
    Reck, M.
    Domine, M.
    Shepherd, F. A.
    McNally, R.
    Renschler, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
    Kim, Young Hak
    Mishima, Michiaki
    CANCER TREATMENT REVIEWS, 2011, 37 (02) : 143 - 150
  • [8] Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients with Sensitive Relapsed SCLC
    Zhang, L.
    Liu, X.
    Cheng, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1088 - S1088
  • [9] A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients (PTS) with small-cell lung cancer (SCLC)
    Agelaki, S
    Agelidou, M
    Blazogiannakis, G
    Tsiafaki, X
    Palamidas, T
    Kouroussis, C
    Kakolyris, S
    Malliotakis, C
    Samonis, G
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S259
  • [10] Effect of Topotecan as Second-Line Chemotherapy for Small Cell Lung Cancer Patients with Interstitial Lung Disease
    Suzuki, H.
    Hirashima, T.
    Kobayashi, M.
    Sasada, S.
    Okamoto, N.
    Uehara, N.
    Matsuura, Y.
    Tamiya, M.
    Morishita, N.
    Higashiguchi, M.
    Tsumori, T.
    Kawase, I.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (06) : 367 - 370
12345